Sohliya AEL. Revumenib: the newly approved food drug administration drug for the treatment of relapsed acute leukemia with a KMT2A translocation. Int J Res Med Sci [Internet]. 2025 Jan. 30 [cited 2025 Sep. 30];13(2):987-8. Available from: https://www.msjonline.org/index.php/ijrms/article/view/14638